These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 208804)

  • 1. Apolipoprotein A-1 in cholestatic liver diseases.
    Yamamoto K; Koga S; Ibayashi H
    Clin Chim Acta; 1978 Jul; 87(1):85-92. PubMed ID: 208804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipoprotein metabolism in cholestasis].
    Patsch W
    Acta Med Austriaca Suppl; 1977; (4):86-7. PubMed ID: 199024
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z; Milewski B
    Mater Med Pol; 1975; 7(4):327-33. PubMed ID: 175222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein abnormalities in cholestasis. I. Electrophoretic and ultracentrifugal analyses.
    Watanabe M
    Acta Med Okayama; 1979 Aug; 33(4):269-85. PubMed ID: 227230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins in plasma from patients with low LCAT activity due to biliary obstruction.
    Danielsson B; Ekman R; Johansson BG; Nilsson-Ehle P; Petersson BG
    Scand J Clin Lab Invest Suppl; 1978; 150():214-7. PubMed ID: 218276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spurious elevation of serum high-density lipoprotein cholesterol in patients with cholestatic liver diseases.
    Chiba H; Osaka T; Iwasaki N; Suzuki H; Akizawa K; Fujisawa S; Intoh S; Watanabe M; Yoshida J; Matsuno K
    Biochem Med Metab Biol; 1991 Dec; 46(3):329-43. PubMed ID: 1793611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cholesteryl ester transfer complex in human plasma.
    Fielding PE; Fielding CJ
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3327-30. PubMed ID: 6774335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LCAT Activity, apolipoprotein A-L and Lipoprotein-X in the parenchymal and cholestatic liver diseases (author's transl)].
    Yamamoto K
    Fukuoka Igaku Zasshi; 1980 Oct; 71(10):574-82. PubMed ID: 7461579
    [No Abstract]   [Full Text] [Related]  

  • 9. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P; Celis H; Desager JP; Fagard R
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical examination of the value of combined determinations of lecithin:cholesterol acyltransferase and lipoprotein-X in the differential diagnosis of liver disease.
    Miller JP; Johnson K
    Clin Chim Acta; 1976 May; 69(1):81-4. PubMed ID: 1269156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative determination of apolipoprotein A in human serum by laser nephelometry].
    Girault A; Loiseau D; Girault M
    Ric Clin Lab; 1981; 11 Suppl 2():19-29. PubMed ID: 6798675
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma lipoprotein changes in experimental cholestasis in the dog.
    Danielsson B; Ekman R; Johansson BG; Petersson BG
    Clin Chim Acta; 1977 Oct; 80(1):157-70. PubMed ID: 198165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCAT.
    Chisholm JW; Paterniti JR; Dolphin PJ
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):145-54. PubMed ID: 11018467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I-containing lipoproteins in human umbilical cord blood. Relation to proapolipoprotein A-I and lecithin:cholesterol acyltransferase.
    Barkia A; Thiemann E; Czekelius P; Wiegel A; Leroy A; Fruchart JC; Steinmetz A
    Biol Neonate; 1991; 59(6):352-7. PubMed ID: 1908326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin: cholesterol acyltransferase activity in patients with chronic liver diseases and positive LP-X tests.
    Jung K; Schimmelpfennig W; Wack R; Neumann R
    Digestion; 1978; 17(5):445-8. PubMed ID: 210070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the Apo E-rich HDL in plasma of patients with cholestasis and its clinical significance].
    Seishima M; Okuno F; Aoki Y; Yoshida H; Yamada M; Ando T; Muto Y; Takahashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 Jun; 81(6):1405-16. PubMed ID: 6471542
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis.
    Simon JB; Poon RW
    Gastroenterology; 1978 Aug; 75(2):177-80. PubMed ID: 208914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.